|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 欧洲肿瘤内科协会对宫颈癌的诊断、治疗和随访所制定的临床实践指南显示文摘2010年底,在意大利米兰召开了欧洲肿瘤年会。会上推出了常见妇科肿瘤的诊治指南。这些指南与国际妇产科联盟(FIGO)、美国国立综合癌症网(NCCN)等的指南有一些差异,但细腻周全,有其特点和重要参考价值。现邀请北京协和医院杨华博士翻译,《国际妇产科学杂志》主编郎景和教授审校,依宫颈癌、子宫内膜癌、卵巢上皮癌、非卵巢上皮癌顺序陆续发表,以飨读者。指南均发表于欧洲肿瘤协会(European Society forMedical Oncology,ESMO)主办的肿瘤年刊 Annals of Oncology,2010,21(Suppl 5)。 | Haie-Meder C Morice P Castiglione M On Behalf of the ESMO Guidelines Working Group 杨华 郎景和 | 2011 | 国际妇产科学杂志2011，38，1： | 21 |
| 2 | Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting显示文摘AIM: To validate the Rockall scoring system for predicting outcomes of rebleeding, and the need for a surgical procedure and death. METHODS: We used data extracted from the Registry of Upper Gastrointestinal Bleeding and Endoscopy including information of 1869 patients with non-variceal upper gastrointestinal bleeding treated in Canadian hospitals. Risk scores were calculated and used to classify patients based on outcomes. For each outcome, we used χ2 goodness-of-fit tests to assess the degree of calibration, and built receiver operating characteristic curves and calculated the area under the curve (AUC) to evaluate the discriminative ability of the scoring system. RESULTS: For rebleeding, the χ2 goodness-of-fit test indicated an acceptable fit for the model [χ2 (8) = 12.83, P = 0.12]. For surgical procedures [χ2 (8) = 5.3, P = 0.73] and death [χ2 (8) = 3.78, P = 0.88], the tests showed solid correspondence between observed proportions and predicted probabilities. The AUC was 0.59 (95% CI: 0.55-0.62) for the outcome of rebleeding and 0.60 (95% CI: 0.54-0.67) for surgical procedures, representing apoor discriminative ability of the scoring system. For the outcome of death, the AUC was 0.73 (95% CI: 0.69-0.78), indicating an acceptable discriminative ability. CONCLUSION: The Rockall scoring system provides an acceptable tool to predict death, but performs poorly for endpoints of rebleeding and surgical procedures. | Robert A Enns Yves M Gagnon Alan N Barkun David Armstrong Jamie C Gregor Richard N Fedorak RUGBE Investigators Group | 2006 | World Journal of Gastroenterology2006，12，48： | 14 |
| 3 | Corrosion behavior of Mg-Y alloy in NaCl aqueous solution | Xin Zhang a,b,c,Kui Zhang a,Xia Deng a,Hongwei Li b,c,Yongjun Li a,Minglong Ma a,Ning Li b,c,Yanlong Wang b,c a State Key Laboratory for Fabrication and Processing of Nonferrous Metals,Beijing General Research Institute for Nonferrous Metals,Beijing 100088,China b Beijing Engineering Research Center for Advanced Manufacturing and Evaluation of Special Vehicle Parts,Beijing 100072,China c Center of Technology,Beijing North Vehicle Group Corporation,Beijing 100072,China | 2012 | Progress in Natural Science:Materials International2012，22，2： | 7 |
| 4 | Usefulness of ω-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study显示文摘AIM: To assess the value of long-chain ω-3 fatty acids (FAs) supplementation in addition to amino-salicylic-acid (5-ASA) in pediatric patients with Crohn's disease (CD).METHODS: Thirty-eight patients (20 males and 18females, mean age 10.13 years, range 5-16 years)with CD in remission were randomized into two groups and treated for 12 mo. Group Ⅰ (18 patients) received 5-ASA (50 mg/kg/d)+ω-3 FAs as triglycerides in gastroresistant capsules, 3 g/d (eicosapentanoic acid, EPA, 400mg/g, docosahexaenoic acid, DHA, 200 mg/g). Group Ⅱ (20 patients) received 5-ASA (50 mg/kg/d)+olive oil placebo capsules. Patients were evaluated for fatty acid incorporation in red blood cell membranes by gas chromatography at baseline 6 and 12 mo after the treatment.RESUJLTS: The number of patients who relapsed at 1year was significantly lower in group Ⅰ than in group Ⅱ(P<0.001). Patients in group Ⅰ had a significant increase in the incorporation of EPA and DHA (P<0.001) and a decrease in the presence of arachidonic acids.CONCLUSION: Enteric-coated ω-3 FAs in addition to treatment with 5-ASA are effective in maintaining remission of pediatric CD. | C Romano S Cucchiara A Barabino V Annese C Sferlazzas SIGENP Italian Study Group of Pediatric Inflammatory Bowel Diseases | 2005 | World Journal of Gastroenterology2005，11，45： | 4 |
| 5 | 河北省文化产业发展现状分析及对策显示文摘发展文化产业已成为人们的共识。河北省文化产业经过近些年发展已具备了一定基础和优势,同时也存在着明显的不足和劣势。要发展河北的文化产业,必须立足于河北实际,更新观念,加强战略研究,实行政企分开,大力培养文化产业经营管理人才,建立健全文化产业法规政策体系。 | Research Group of Publicity Department, C C P Committee of Hebei Province(Publicity Department of C C P Committee of Hebei Province, Shijiazhuang, Hebei 050052,China) | 2003 | 河北师范大学学报(哲学社会科学版)2003，26，1： | 3 |
| 6 | 输尿管及膀胱深部浸润型子宫内膜异位症的手术治疗效果显示文摘目的报告泌尿道子宫内膜异位症的手术治疗效果以及探讨保守型手术和根治性手术的选择。方法对5个手术科室参与的输尿管或膀胱深部浸润型子宫内膜异位症外科治疗的CIRENDO前瞻性数据库管理数据进行回顾性研究。对术前、术中和术后数据结果进行分析。结果数据库中的数据显示,30例中有15例为输尿管子宫内膜异位症,14例为膀胱结节病变(bladder nodules),1例同时存在这2种类型的病变。输尿管松解术14例,其中输尿管完全恢复解剖解构10例。4例40岁以上的患者术后出现闭经和可忍受的中度输尿管狭窄,其中3例好转,1例行二次输尿管切除和输尿管膀胱吻合术。4例初次手术行输尿管切除术。5例输尿管标本中发现2例输尿管子宫内膜异位症。4例并发症中有2例与输尿管结节病灶切除有关,2例与膀胱子宫内膜异位病灶切除有关。远期效果较为满意,如疼痛症状显著改善、泌尿系不适症状消失,仅有1例较长时间膀胱神经功能障碍。结论建议保守性手术联合术后假绝经疗法治疗大多数泌尿道子宫内膜异位症。尽管总体结果满意,由于术中可能同时施行其他一些复杂手术如结直肠手术,术后并发症的风险仍不容忽视。 | 陈旭 刘彦 Francisc Rozsnyai Horace Roman Benoit Resch Fabrice Dugardin Juan Berrocal Gérme Descargues Remi Schmied Malik Boukerrou Loc Marpeau CIRENDO Study Group | 2013 | 中国微创外科杂志2013，13，2： | 3 |
| 7 | PHOTOELECTROCHEMICAL STUDY OF PASSIVE LAYERS ON COPPER ELECTRODES IN SOME ALKALINE MEDIA显示文摘PHOTOELECTROCHEMICALSTUDYOFPASSIVELAYERSONCOPPERELECTRODESINSOMEALKALINEMEDIA①A.Kamkina,1,ZhouGuodinga,XuQunjiebandB.H.cLooaE... | A. Kamkina,1, Zhou Guodinga, Xu Qunjieb and B. H.c Loo a Electrochemical Research Group, Shanghai Institute of Electric Power, Shanghai 200090, P. R. China b Corrosion Prevention Center, East China University of | 1998 | 中国有色金属学会会刊:英文版1998，8，2： | 2 |
| 8 | Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function显示文摘 | Hasslacher C Multinational Repaglinide Renal Study Group | 2003 | Diabetes Care2003，26，3： | 1 |
| 9 | Relevance of breast cancer hormone re ceptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta analysis of randomised trials显示文摘 | Early Breast Cancer Trialists' Collaborative Group(EBCTCG) Da- vies C Godwin J | 2011 | Lancet2011，378，9793： | 1 |
| 10 | Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double blind, placebo controlled trial显示文摘 | Niederau C Strohmeyer G Heintges T Peter K Gopfert E (Leich Study Group) | 1998 | Hepato-Gastroenterology1998，45，21： | 1 |
| 11 | Oxaliplatin added to fluoro-uracil-based preoperative chemoradiotherapy and postop-erative chemotherapy of locally advanced rectal cancer(the German CAO/ARO/A10-04 study):final results ofthe multicentre, open-label, randomised, phase3 trial 显示文摘 | RODEL C GRAEVEN U FIETKAU R et a/GermanRectal Cancer Study Group | 2015 | LancetOncol2015，16，8： | 1 |
| 12 | General anaesthesia versus local anaesthesia for carotid surgery(GALA):a multicentre,randomised controlled trial显示文摘 | GALA Trial Collaborative Group Lewis S C Warlow C P | 2008 | Lancet2008，372，9656： | 1 |
| 13 | The impact of environmental policy instruments on innovation: a review of energy and automotive industry studies 显示文摘 | BERGEK A BERGGREN C KITE Research Group | 2014 | Ecological economics2014，106，： | 1 |
| 14 | Pranlukast, anovel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma显示文摘 | Pujer J - C on behalf of an international study group | 1997 | Thorax1997，52，： | 1 |
| 15 | Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline 显示文摘 | Tonelli M Wanner C Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members | 2014 | Ann Intern Med2014，160，3： | 1 |
| 16 | Randomized trial of plasma exchange,intravenous immnnoglobulin,and combined treatments in Giillain-Barre syndrome显示文摘 | Plasma Exchange-Sandoglobulin C uillain-Barre syndrome Trial Group | 1997 | Loncet1997，349，3： | 1 |
| 17 | Severe hepatotoxicity during combination antiretroviral treatment:incidence,liver histology,and outcome显示文摘 | Puoti M Torti C Ripamonti D the HIV-HCV Co-infection Study Group | 2003 | J Acquir Immune Defic Syndr2003，32，： | 1 |
| 18 | Rituximab in high-grade lymphoma显示文摘 | Zwick C Murawski N Pfreundschuh M German High-Grade Non-Hodgkin Lymphoma Study Group | | 0，，02： | 1 |
| 19 | Comparisons between different polyche- motherapy regimens for early breast cancer: meta-analyses of long- term outcome among 100,000 women in 123 randomised trials 显示文摘 | Early Breast Cancer Trialists' Collaborative Group ( EBCTCG ) Peto R Davies C | 2012 | Lancet2012，379，9814： | 1 |
| 20 | Comparisons between dif- ferent polychemotherapy regimens for early breast cancer: recta-analyses of long-term outcome among 100,000 wom- en in 123 randomised trials显示文摘 | Early Breast Cancer Trialists' Collaborative Group (E- BCTCG) Peto R Davies C | 2012 | Lancet2012，379，9814： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员